Nightstar Therapeutics (NITE) Financials

$384.4 M

Mkt cap, 15-May-2018
Net income (H1, 2017)-7.7 M
EBIT (H1, 2017)-7.7 M
Cash, 30-Jun-201769.6 M

Revenue/Financials

Income Statement

Annual

USDFY, 2015FY, 2016

R&D expense

7.2 m10.2 m

General and administrative expense

2.1 m2.1 m

Operating expense total

9.3 m12.2 m

EBIT

(9.3 m)(12.2 m)

Interest income

9 k22 k

Net Income

(13.6 m)(12.2 m)

Half Year

USDH1, 2016H1, 2017

R&D expense

5.1 m6.3 m

General and administrative expense

812 k1.4 m

Operating expense total

5.9 m7.7 m

EBIT

(5.9 m)(7.7 m)

Interest income

21 k6 k

Net Income

(5.9 m)(7.7 m)

Balance Sheet

Annual

USDFY, 2015FY, 2016

Cash

10.7 m10.1 m

Prepaid Expenses

3.1 m4.1 m

Current Assets

13.8 m14.2 m

PP&E

253 k363 k

Total Assets

14.1 m14.6 m

Accounts Payable

1 m1.2 m

Current Liabilities

3 m5.6 m

Total Liabilities

3 m5.6 m

Additional Paid-in Capital

32 m43.5 m

Retained Earnings

(20.1 m)(32.3 m)

Total Equity

11.1 m9 m

Financial Leverage

1.3 x1.6 x

Half Year

USDH1, 2017

Cash

69.6 m

Prepaid Expenses

6.5 m

Current Assets

76.1 m

PP&E

342 k

Total Assets

76.4 m

Accounts Payable

3 m

Current Liabilities

9.7 m

Total Liabilities

9.7 m

Common Stock

1 k

Additional Paid-in Capital

107.1 m

Retained Earnings

(40 m)

Total Equity

66.7 m

Financial Leverage

1.1 x

Cash Flow

Annual

USDFY, 2015FY, 2016

Net Income

(13.6 m)(12.2 m)

Depreciation and Amortization

40 k138 k

Accounts Payable

384 k419 k

Cash From Operating Activities

(9.7 m)(10.1 m)

Purchases of PP&E

(289 k)(306 k)

Cash From Investing Activities

(289 k)(306 k)

Cash From Financing Activities

14 m11.3 m

Net Change in Cash

3.5 m(554 k)

Half Year

USDH1, 2016H1, 2017

Net Income

(5.9 m)(7.7 m)

Depreciation and Amortization

51 k95 k

Accounts Payable

91 k1.7 m

Cash From Operating Activities

(5.9 m)(5.7 m)

Purchases of PP&E

(186 k)(55 k)

Cash From Investing Activities

(186 k)(55 k)

Cash From Financing Activities

63.4 m

Net Change in Cash

(6.8 m)59.5 m

Ratios

USDY, 2017

Financial Leverage

1.1 x
Report incorrect company information